PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1663464
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1663464
Skin Perfusion Pressure Testing Devices Market size was valued at US$ 1,851.6 Million in 2024, expanding at a CAGR of 9.60% from 2025 to 2032.
Skin perfusion pressure testing has become a precise way to determine how much blood is getting to the damaged tissue. The relaxation of carefully regulated occlusion must be prioritized in order to restore normal microcirculatory blood flow, which requires skin perfusion pressure (SPP). Devices for skin perfusion pressure testing are minimally invasive tools used to measure blood flow rate and assess segmental blood pressures, such as the ankle-brachial index (ABI). In order to diagnose peripheral artery illnesses such as critical limb ischemia and to determine the best level of amputation, among other things, skin perfusion pressure devices are widely used. Key factors driving the global skin perfusion pressure testing devices market include deep penetration channels for distribution of these devices to a variety of end-user segments, including hospitals and ambulatory surgical centres, which provide better access in developed markets; growing demand for the newest skin perfusion pressure testing devices; and manufacturers' shifting focus on creating better devices. Skin perfusion pressure is a non-invasive diagnostic technique that measures systolic pressure in microcirculation and quantitatively examines blood flow. Additionally, patients with peripheral arterial disease (PAD) and diabetes are frequently advised to undergo skin perfusion pressure testing; their rising incidence will increase market demand for skin perfusion pressure testing equipment.
Skin Perfusion Pressure Testing Devices Market- Market Dynamics
Increasing patient preferences for minimally invasive procedures
The skin perfusion pressure testing devices market would benefit from rising demand for minimally invasive operations because the number of people with chronic illnesses, such as diabetes, and the elderly population has been growing, which has created a sizable patient base. The popularity of minimally invasive operations is growing due to the advantages they offer both patients and medical professionals. Patients' preferences have shifted in favour of minimally invasive surgeries because of their advantages over invasive procedures, including smaller incisions, less pain, less tissue damage, the avoidance of surgical scars, quicker recovery, fewer risks of infection, and shorter hospital stays. These methods are becoming more and more popular in the medical world since they help patients and doctors alike by reducing the agony that open operations cause and, most importantly, preventing bodily harm and surgery. The benefits of using skin perfusion pressure testing devices, such as reduced discomfort, cheaper surgical expenses, and minor complications in rare situations, are anticipated to support market growth in the upcoming years.
Skin Perfusion Pressure Testing Devices Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 9.60% over the forecast period (2025-2032)
Based on mobility segmentation, the car-based devices category was predicted to show maximum market share in the year 2024
Based on end use segmentation, hospitals were the leading segment in 2024
On the basis of region, North America was the leading revenue generator in 2024
The Global Skin Perfusion Pressure Testing Devices Market is segmented on the basis of Mobility, Product, End Use, and Region.
Based on mobility, the market is divided into Cart-based devices and Portable devices. In 2024, the cart-based devices category held a dominant market share. Cart-based devices are stationary units that are commonly found in specialized clinics and hospitals. They offer advanced features and functionalities along with extensive vascular evaluation capabilities. These devices provide doctors with a full platform for vascular examination since they have larger screens, significant data storage capabilities, and are frequently coupled with other diagnostic modalities. Cart-based devices give physicians the resources they need for precise diagnosis and treatment planning, making them ideal for in-depth evaluations and intricate treatments.
On the basis of product, the market is segregated into Laser doppler, Ultrasound, Photoplethysmography, and Others. In 2024, the market was dominated by the laser doppler category. In order to provide accurate and quantitative evaluations of tissue perfusion, laser Doppler skin perfusion pressure testing devices use the Doppler effect to quantify blood flow velocity in superficial tissues. These technologies enable early identification of vascular impairment and guide treatment measures by giving clinicians objective measurements of microcirculation based on changes in the frequency of reflected laser light. Devices that use laser Doppler are especially useful for determining perfusion in areas with a restricted blood supply, like ischemic limbs and chronic wounds.
Skin Perfusion Pressure Testing Devices Market- Geographical Insights
In 2024, North America held a dominant position in the global market for Skin Perfusion Pressure Testing Devices. North America leads the world in both technological improvements and the adoption rates of skin perfusion pressure testing devices because it is one of the most developed healthcare markets. The high frequency of vascular illnesses and chronic wounds in the area fuels the need for sophisticated diagnostic equipment. Furthermore, this region's market expansion is supported by a strong healthcare infrastructure, advantageous reimbursement policies, and rising healthcare spending.
However, throughout the projected period, the Asia-Pacific region is anticipated to see the fastest CAGR driven by the rising incidence of heart disease and diabetes, especially in nations like China and India. The use of skin perfusion pressure testing equipment in this region is influenced by rising healthcare investments, bettering healthcare infrastructure, and increased vascular health awareness-additionally, a sizable patient base and unexplored market prospects fuel market expansion in the Asia Pacific region.
There is fierce competition among well-known firms like Viasonix, Moor Instruments, Vasamed, ELCAT, CorVascular Diagnostics, and others in the global market for skin perfusion pressure testing equipment. To meet the increasing need for precise diagnostic instruments in the treatment of wounds and vascular diseases, these major manufacturers consistently make investments in R&D to improve their product lines for measuring skin perfusion pressure. As businesses seek to increase their geographic reach and product portfolios, market expansion tactics such as partnerships, mergers, and acquisitions are common. In addition, the competitive environment of this market is greatly influenced by regulatory approvals and technology developments, which demonstrate a dedication to enhancing healthcare results. For instance, in July 2023, the Swedish company PeriMed AB, which developed epidermal blood flow monitoring devices, was purchased by Smith & Nephew (UK). Smith & Nephew's current line of wound care products and technologies was enhanced by this acquisition, expanding their offers in the healthcare industry.
Recent Development
February 2024: Leading Nordic healthcare investor Serendipity Partners has purchased a substantial 49% share in Perimed AB, a prominent leader in the vascular medical devices market. This marks a significant milestone for the company. This collaboration guarantees Perimed's ongoing development and product expansion.
January 2023: Vasamed (Sweden), a top producer of skin perfusion pressure testing equipment, was purchased by MicroPort Scientific Corporation (China). Through this transaction, MicroPort gained access to Vasamed's cutting-edge product line and solidified its place in the wound care industry.